| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | WVE | Ordinary Shares | Options Exercise | $294,120 | +36,000 | $8.17 | 36,000 | 08 Nov 2024 | Direct | F1 | |
| transaction | WVE | Ordinary Shares | Sale | $576,000 | -36,000 | -100% | $16.00 | 0 | 08 Nov 2024 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | WVE | Share Option (right to buy) | Options Exercise | $0 | -36,000 | -100% | $0.000000 | 0 | 08 Nov 2024 | Ordinary Shares | 36,000 | $8.17 | Direct | F2 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2023. |
| F2 | The share options that were exercised in this reportable transaction were fully vested. |
SVP, Corporate Development, Head of Emerging Areas